Valuation : Myomo, Inc.

Market Cap 51.49M 44.36M 42.01M 38.07M 71.43M 4.92B 71.79M 499M 192M 2.5B 193M 189M 7.91B P/E 2026 *
-4.14x
P/E 2027 * -5.46x
Enterprise Value 51.49M 44.36M 42.01M 38.07M 71.43M 4.92B 71.79M 499M 192M 2.5B 193M 189M 7.91B EV / Sales 2026 *
1.13x
EV / Sales 2027 * 1.01x
Free-Float
89.32%
Yield 2026 *
-
Yield 2027 * -
1 week-9.72%
Current month-12.75%
1 month-13.91%
3 months-5.11%
6 months+81.87%
Current year+42.86%
1 week 1.25
Extreme 1.25
1.46
1 month 1.25
Extreme 1.25
1.88
Current year 0.6
Extreme 0.605
1.88
1 year 0.6
Extreme 0.605
1.88
3 years 0.6
Extreme 0.605
7.17
5 years 0.37
Extreme 0.369
14.35
10 years 0.37
Extreme 0.369
695.89
Manager TitleAgeSince
Chief Executive Officer 72 2011-06-30
Director of Finance/CFO 64 2019-02-17
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 72 2016-07-31
Director/Board Member 79 2012-02-29
Director/Board Member 80 2014-08-31
Date Insider Type Main position Quantity % Market Cap. Importance
9/2/26 Sell

Director

-15,000 0.0379%
8/20/26 Sell

Chief Technology Officer

-17,250 0.0446%
8/20/26 Sell

Chief Technology Officer

-17,500 0.0453%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-9.72%+44.57%+16.07% 51.49M
-1.36%-5.89%-23.14%-0.49% 176B
-0.72%-3.41%-3.49%+11.74% 116B
+0.19%-2.83%+6.20%+80.93% 61.36B
-1.92%-6.01%+8.80%+41.11% 49.42B
+0.81%-3.73%-6.67%-33.43% 48.44B
-1.75%-5.54%+9.25%-22.61% 31.33B
+0.43%-11.10% - - 28.56B
+0.58%+1.84%+31.28%-12.82% 24.37B
+0.49%-7.65%-12.44%+4.86% 21.57B
Average -0.33%-5.54%+6.04%+9.48% 55.79B
Weighted average by Cap. -0.69%-4.90%-6.07%+10.85%

Financials

2026 *2027 *
Net sales 45.6M 39.29M 37.21M 33.72M 63.27M 4.36B 63.59M 442M 170M 2.22B 171M 168M 7B 51.21M 44.12M 41.78M 37.87M 71.04M 4.89B 71.4M 496M 191M 2.49B 192M 188M 7.87B
Net income -13.37M -11.52M -10.91M -9.88M -18.54M -1.28B -18.64M -130M -49.81M -650M -50.2M -49.1M -2.05B -10.52M -9.07M -8.58M -7.78M -14.6M -1.01B -14.67M -102M -39.2M -511M -39.52M -38.65M -1.62B
Net Debt - -
Logo Myomo, Inc.
Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. The Company develops and markets the MyoPro product line, which is a myoelectric-controlled upper limb brace, or orthosis. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury or other neuromuscular disease or injury. MyoPro senses a patient’s own electromyography (EMG) signals through non-invasive sensors on the arm and can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. MyoPro’s control technology utilizes an advanced human-machine interface based on non-invasive, patented electromyography, or EMG, control technology.
Employees
195
Date Price Change Volume
26-09-11 US$1.300 0.00% 324,939
26-09-10 US$1.300 -2.26% 234,346
26-09-09 US$1.330 -0.75% 190,252
26-09-08 US$1.340 -6.94% 434,665
26-09-04 US$1.440 +2.86% 378,679
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
1.300USD
Average target price
4.640USD
Spread / Average Target
+256.92%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!